These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 12143188)

  • 1. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
    Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
    Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Cianci R; Gasbarrini A; Pirozzi G; Gasbarrini G
    Hepatogastroenterology; 2000; 47(34):1176-9. PubMed ID: 11020908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
    Cammarota G; Cannizzaro O; Tursi A; Papa A; Gasbarrini A; Cuoco L; Cianei R; Armuzzi A; Fedeli P; Fedeli G; Gasbarrini G
    Aliment Pharmacol Ther; 1998 Jun; 12(6):539-43. PubMed ID: 9678813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    Vakil N; Cutler A
    Am J Gastroenterol; 1999 May; 94(5):1197-9. PubMed ID: 10235192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH
    Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial.
    Svoboda P; Kantorová I; Ochmann J; Doubek J; Kozumplík L; Marsová J
    Hepatogastroenterology; 1997; 44(15):886-90. PubMed ID: 9222709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
    Kolkman JJ; Tan TG; Oudkerk Pool M; Van Kleef WA; Geraedts AA; Timmerman RJ; Crobach LF; Nicolai JJ; Wolff AA; Van Der Laan J
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1123-9. PubMed ID: 9663840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Ojetti V; Cianci R; Pastorelli A; Armuzzi A; Gentiloni N; Gasbarrini A; Pirozzi G; Gasbarrini G
    Aliment Pharmacol Ther; 2000 Jan; 14(1):73-7. PubMed ID: 10632648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure.
    Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM
    Helicobacter; 2007 Feb; 12(1):68-73. PubMed ID: 17241304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication.
    Akyildiz M; Akay S; Musoglu A; Tuncyurek M; Aydin A
    Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial).
    Vcev A; Vceva A; Kurbel S; Takac B; Stimac D; Ivandić A; Ostojić R; Barbir A; Hovat D; Mihaljević S
    Wien Klin Wochenschr; 2001 Dec; 113(23-24):939-41. PubMed ID: 11802510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
    Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
    Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
    Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
    Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
    Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    de Boer WA; Haeck PW; Otten MH; Mulder CJ
    Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.